IP Library Granted Patent US 6,858,606
Granted Patent B2
US 6,858,606 · App. 10/305,039 · Granted Feb 22, 2005

Pyrimidine compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,606
App. No.
10/305,039
Granted
Feb 22, 2005
Kind
B2
Abstract

This invention features pyrimidine compounds of formula (I): R 1 is in which one of R a and R b is H or alkyl, and the other is aryl or heteroaryl optionally substituted with R d and R e m ; each of R 2 and R 4 is H; R 3 is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl; R 5 is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is NR c ; Y is covalent bond, CH 2 , C(O), C═N—R c , C═N—OR c , C═N—SR c , O, S, S(O), S(O 2 ), or NR c ; Z is N or CH; one of U and V is N, and the other is CR c ; and W is O, S, S(O), S(O 2 ), NR c , or NC(O)R c ; in which R c is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl; R d is halogen, CN, alkyl alkyloxy, alkylcarbonyl, alkyloxycarbonyl, aryloxycarbonyl, heteroaryloxycarbonyl, hydroxyalkyl, alkylamino, or alkylaminocarbonyl; R e is halogen, CN, hydroxyl, alkyl, aryl, heteroaryl, alkoxyl, aryloxyl, or heteroaryloxyl; and m is 0, 1, 2, 3, or 4. The pyrimidine compounds can be used to treat an IL-12 overproduction-related disorder (e.g., rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus).

Claims (53)

1. A compound of formula (I):

wherein R 1 is

in which one of R a and R b is H or alkyl, and the other is aryl or heteroaryl optionally substituted with R d and R e m ;

each of R 2 and R 2 is H;

R 3 is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl;

R 5 is H or alkyl;

n is 0,1, 2, 3, 4, 5, or 6;

X is NR c ;

Y is covalent bond, CH2, C(0), C═N—R c , C═N—OR c , C═N—SR c , 0, S, S(0), S(02), or NR c ;

Z is N or CH;

one of U and V is N, and the other is CR c and

W is O, S, S(O), S(O2), NR c , or NC(0)R c ;

in which R o is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl;

R d is halogen, CN, alkyl, alkyloxy, alkylcarbonyl, alkyloxycarbonyl, aryloxycarbonyl, heteroaryloxycarbonyl, hydroxyalkyl, alkylamino, or alkylaminocarbonyl;

Re is halogen, CN, hydroxyl, alkyl, aryl, heteroaryl, alkoxyl, aryloxyl, or heteroaryloxyl; and

m is 0, 1, 2, 3, or 4.

2. The compound of claim 1 , wherein one of R a and R b is H or alkyl; and the other is:

in which Rd, Re, and m are as defined in claim 1 .

3. The compound of claim 2 , wherein one of R a and R b is H; and the other is:

in which R d is as defined in claim 1 .

4. The compound of claim 1 , wherein X is NH.

5. The compound of claim 4 , wherein one of R a and R b is H or alkyl; and the other is:

in which R d , R e , and m are as defined in claim 1 .

6. The compound of claim 5 , wherein one of R a and R b is H; and the other is:

in which R d is as defined in claim 1 .

7. The compound of claim 1 , wherein n is 2 .

8. The compound of claim 1 , wherein R 3 is heteroaryl or heterocyclyl.

9. The compound of claim 1 , wherein Y is O.

10. The compound of claim 9 , wherein n is 2.

11. The compound of claim 10 , wherein R 3 is heteroaryl or heterocyclyl.

12. The compound of claim 1 , wherein U is N and Y is CH.

13. The compound of claim 12 , wherein Z is N and W is O.

14. The compound of claim 13 , wherein Y is O.

15. The compound of claim 14 , wherein n is 2.

16. The compound of claim 15 , wherein R 3 is heteroaryl or heterocyclyl.

17. The compound of claim 16 , wherein R 3 is pyridin-2-yl.

18. The compound of claim 17 , wherein X is NH.

19. The compound of claim 18 , wherein one of R a and R b is H or alkyl; and the other is:

in which R d , R e , and m are as defined in claim 1 .

20. The compound of claim 19 , wherein one of R a and R b is H; and the other is:

in which R d is as defined in claim 1 .

21. The compound of claim 20 , wherein Rd is halogen.

22. The compound of claim 20 , wherein Rd is CN, hydroxyalkyl, alkylamino, alkylaminocarbonyl alkyloxycarbonyl.

23. The compound of claim 20 , wherein Rd is alkyloxycarbonyl.

24. The compound of claim 16 , wherein R 3 is 1H-pyridin-2-one.

25. The compound of claim 24 , wherein X is NH.

26. The compound of claim 25 , wherein one of R a and R b is H or alkyl; and the other is:

in which R d , R e , and m are as defined in claim 1 .

27. The compound of claim 26 , wherein one of Ra and Rb is H; and the other is:

in which Rd is as defined in claim 1 .

28. The compound of claim 27 , wherein Rd is alkyl.

29. The compound of claim 27 , wherein Rd is halogen.

30. The compound of claim 27 , wherein Rd is methoxycarbonyl.

Assignments (1)
CHANGE OF NAME Recorded Aug 9, 2017
From: SYNTA PHARMACEUTICALS CORPORATION
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 043239/0357 →